article thumbnail

Merck Life Sciences banks on RPA to streamline regulatory compliance

CIO

The pharmaceutical industry is a highly regulated one, especially for multinationals doing business across the globe. Although non-compliance with regulations can attract exorbitant fines, many pharma companies still depend on manual process for these value chains.

Banking 368
article thumbnail

Industry clouds prove their business value

CIO

Perhaps most important, Idorsia taps into Veeva’s evolving knowledge base, which encompasses data from other customers such as major pharmaceuticals giants Merck, Bayer, and Kronos, the CIO says. For enterprises like Idorsia whose tech stacks aren’t their key differentiator, the value proposition of industry clouds is compelling.

Business 414
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Cloud is Spectacularly Transforming the Manufacturing Sector

Smart Data Collective

The cloud also supports manufacturers’ integration into global supply, production, and value chains. Supports Manufacturing Supply Chain Integration. For example, the pharmaceutical company Pfizer has recently been leveraging cloud computing to completely reengineer its complicated global supply chain.

article thumbnail

Lithium – The Energy Transition Catalyst

Evalueserve

Lithium has many other applications, such as in grid-scale energy storage, aircraft, glass ceramics, aluminum alloys, and pharmaceuticals. As a large proportion of the world’s energy transition plan will bank upon the use of lithium, recycling and development of a circular economy around the lithium value chain is of utmost importance.

article thumbnail

AstraZeneca’s Axial Transformation: A Digital Backbone for Innovation

Timo Elliot

Axial: The Strategic Backbone for Bold Ambition 2030 An overview of the Axial program At the heart of AstraZeneca’s Bold Ambition 2030 lies “Axial”, an ambitious initiative to modernize its operations and propel the pharmaceutical giant toward industry leadership.

article thumbnail

Global Healthcare Industry – M&A and Capital Market Landscape Update

Evalueserve

Buyers are also re-assessing where they fit in the value chain and whether M&A would be the right step forward. These companies will be able to reshape the competitive landscape of the pharmaceutical industry. This is expected to curb transactions that are responsible for raising prices or dampening innovation in the sector.

Capital 98
article thumbnail

Procurement Intelligence Spotlight: Vishal Suri

Evalueserve

Technologies such as block-chain and business models like Amazon B2B are just a few examples of what companies are experimenting with. The disruptions arising from these models have the potential to transform different parts of the sourcing value chain. . Sustainability continues to be the critical mega trend in this sector.